☆ 4.6 Editorial Material

Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Survival in Sepsis: Causal Inference Through Human Genetics

CRITICAL CARE MEDICINE (2019)

期刊

CRITICAL CARE MEDICINE

卷 47, 期 3, 页码 489-491

出版社

LIPPINCOTT WILLIAMS & WILKINS

DOI: 10.1097/CCM.0000000000003609

关键词

lipid and lipoprotein metabolism; Mendelian randomization; molecular genetics; proprotein convertase subtilisin/kexin type 9; sepsis

类别

Critical Care Medicine

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Beyond Lipids: The Role in Oxidative Stress and Thrombosis

Vittoria Cammisotto, Francesco Baratta, Paola G. Simeone, Cristina Barale, Enrico Lupia, Gioacchino Galardo, Francesca Santilli, Isabella Russo, Pasquale Pignatelli

Summary: PCSK9 is involved in cholesterol metabolism and plays a role in the development of atherosclerosis and atherothrombotic processes, promoting plaque formation and oxidative stress.

ANTIOXIDANTS (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Modulation of vascular endothelial inflammatory response by proprotein convertase subtilisin-kexin type 9

Alex K. K. Leung, Yuan Chao Xue, Antyrah de Guzman, Guilherme Grzelkovski, HyeJin Julia Kong, Kelly R. Genga, James A. Russell, John H. Boyd, Gordon A. Francis, Keith R. Walley

Summary: This study found that PCSK9 reduces the uptake of LPS in vascular endothelial cells through LDLR-mediated endocytosis, leading to a decrease in the inflammatory response. This suggests that PCSK9 inhibition may have additional effects on vascular endothelial inflammation.

ATHEROSCLEROSIS (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

High-Throughput Screening Identifies MicroRNAs Regulating Human PCSK9 and Hepatic Low-Density Lipoprotein Receptor Expression

Coen van Solingen, Scott R. Oldebeken, Alessandro G. Salerno, Amarylis C. B. A. Wanschel, Kathryn J. Moore

Summary: The discovery of PCSK9 and its role in LDL regulation has led to the rapid development of therapeutic PCSK9 inhibitors. Research has identified certain microRNAs that can reduce PCSK9 expression, leading to increased LDLR expression in hepatic cells, which may have therapeutic implications for manipulating LDLR expression and cholesterol levels in the liver.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

添加到收藏夹

Article Cell Biology

The rs508487, rs236911, and rs236918 Genetic Variants of the Proprotein Convertase Subtilisin-Kexin Type 7 (PCSK7) Gene Are Associated with Acute Coronary Syndrome and with Plasma Concentrations of HDL-Cholesterol and Triglycerides

Gilberto Vargas-Alarcon, Oscar Perez-Mendez, Hector Gonzalez-Pacheco, Julian Ramirez-Bello, Rosalinda Posadas-Sanchez, Galileo Escobedo, Jose Manuel Fragoso

Summary: Genetic variants of the PCSK7 gene are significantly associated with the development of ACS and dyslipidemia, potentially increasing the risk of ACS.

CELLS (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Diverse Effects of Cilostazol on Proprotein Convertase Subtilisin/Kexin Type 9 between Obesity and Non-Obesity

Po-Wei Chen, Shih-Ya Tseng, Hsien-Yuan Chang, Cheng-Han Lee, Ting-Hsing Chao

Summary: The study reveals that Cilostazol can regulate the expression of PCSK9 through enhancing the PPARγ pathway, thus impacting cholesterol homeostasis. It was observed that Cilostazol significantly reduces PCSK9 levels in high-fat diet-induced obese mice and obese patients, indicating its therapeutic potential for obesity-related dyslipidemia.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Article Medical Laboratory Technology

Biological variation of proprotein convertase subtilisin/kexin type 9 (PCSK9) in human serum

Antonin Jabor, Tereza Vackova, Zdenek Kubicek, Jitka Komrskova, Marek Protus, Janka Franekova

Summary: The study evaluated the biological variation of serum PCSK9, finding a high within-subject variability in healthy individuals, suggesting that common reference intervals can be used to interpret its values.

CLINICA CHIMICA ACTA (2021)

添加到收藏夹

Article Medicine, General & Internal

Rapid Decline of Serum Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) in Non-Cirrhotic Patients with Chronic Hepatitis C Infection Receiving Direct-Acting Antiviral Therapy

Jonathan Grimm, Georg Peschel, Martina Mueller, Doris Schacherer, Reiner Wiest, Kilian Weigand, Christa Buechler

Summary: This study found that serum PCSK9 levels were associated with liver injury and inflammation in cirrhotic HCV patients, but not with LDL levels. After DAA therapy, PCSK9 decreased and LDL increased in non-cirrhotic HCV patients, while no changes were observed in the cirrhotic group.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

High-sugar feeding and increasing cholesterol levels in infants

Petra Zubin Maslov, Joseph A. Hill, Thomas F. Luscher, Jagat Narula

Summary: Hypercholesterolaemia is a significant risk factor for cardiovascular disease, with cholesterol levels already increasing in early life. In the USA, only 25% of infants are exclusively breastfed, and formula feeding may lead to fluctuations in blood glucose and insulin levels in infants.

EUROPEAN HEART JOURNAL (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Proprotein convertase subtilisin/kexin type 9 is associated with atherosclerosis in patients with Behcet's disease

Rabia Aydogan Baykara, Pinar Diydem Yilmaz, Mevlut Hakan Goktepe, Cengiz Kadiyoran, Mustafa Ogul, Adem Kucuk, Medine Cumhur Cure, Erkan Cure

Summary: There is a strong independent association between subclinical atherosclerosis and PCSK9 in patients with Behcet's disease. However, there may be no independent association between PCSK9 and disease activity.

CLINICAL AND EXPERIMENTAL HYPERTENSION (2022)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Association Between Circulating Proprotein Convertase Subtilisin/Kexin Type 9 and Major Adverse Cardiovascular Events, Stroke, and All-Cause Mortality: Systemic Review and Meta-Analysis

Yimo Zhou, Weiqi Chen, Meng Lu, Yongjun Wang

Summary: This meta-analysis found a significant association between high circulating PCSK9 concentration and the risk of MACEs, with a linear dose-response relationship observed. However, no significant correlation was found with stroke or all-cause mortality. Further well-designed studies are needed to explore the relationships between PCSK9 concentration and stroke and mortality.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Mendelian Randomization Study of PCSK9 and HMG-CoA Reductase Inhibition and Cognitive Function

Daniel B. Rosoff, Andrew S. Bell, Jeesun Jung, Josephin Wagner, Lucas A. Mavromatis, Falk W. Lohoff

Summary: This genetics-based study found that long-term PCSK9 inhibition had a neutral cognitive profile, while HMGCR inhibition had adverse effects on cognitive performance, reaction time, and cortical surface area. Neither PCSK9 nor HMGCR inhibition impacted biomarkers of Alzheimer's disease progression or Lewy body dementia risk.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Evolocumab loaded Bio-Liposomes for efficient atherosclerosis therapy

Zhenxian Li, Haimei Zhu, Hao Liu, Dayue Liu, Jianhe Liu, Jiazheng Jiang, Yi Zhang, Zhang Qin, Yijia Xu, Yuan Peng, Bin Liu, Yun Long

Summary: In this study, a biomimetic nanoliposome loaded with Evolocumab (a PCSK9 inhibitor) was developed using nano-materials to alleviate atherosclerosis. The results showed that this nanoliposome can inhibit the phenotypic transition, excessive proliferation, and migration of VSMCs. Additionally, it significantly decreased the expression of PCSK9 in serum and VSMCs within the plaque of ApoE(-/-) mice.

JOURNAL OF NANOBIOTECHNOLOGY (2023)

添加到收藏夹

Article Environmental Sciences

The role of proprotein convertase subtilisin/kexin type-9 concentration and paraoxonase 1 activities in the blood of women with polycystic ovary syndrome

Anna Bizon, Grzegorz Franik, Pawel Madej

Summary: This study found significantly higher PCSK9 concentration and lower high-density lipoprotein concentration in the serum of women with PCOS compared to those without, as well as significant differences in paraoxonase 1 activities. Higher PCSK9 concentration in women with PCOS, especially those with insulin resistance, may be associated with hormonal concentrations. The study suggests that changes in paraoxonase 1 activities and lipid profile parameters in women with PCOS could be linked to metabolism disorders, but further research is needed due to the small sample size.

ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2021)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Association Between Circulating Proprotein Convertase Subtilisin/Kexin Type 9 Concentrations and Cardiovascular Events in Cardiovascular Disease: A Systemic Review and Meta-Analysis

Jiahui Liu, Fangfang Fan, Xingyu Luo, Wenjun Ji, Yaokun Liu, Yan Zhang, Bo Zheng

Summary: The study found a significant positive correlation between high PCSK9 concentrations and increased risk of cardiovascular events, especially in stable CVD patients, patients on statin therapy, and Asian patients.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Lipoprotein(a) Reduction With Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: A Systematic Review and Meta-analysis

Ioannis Farmakis, Ioannis Doundoulakis, Areti Pagiantza, Stefanos Zafeiropoulos, Christina Antza, Haralambos Karvounis, George Giannakoulas

Summary: PCSK9 inhibitors have been shown to lower Lipoprotein(a) levels, with significant heterogeneity in their effects. Differences in comparator and treatment duration can influence the impact of PCSK9 inhibitors on Lipoprotein(a) levels.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2021)

添加到收藏夹

Article Oncology

COVID-19 bimodal clinical and pathological phenotypes

Sabrina S. Batah, Maira N. Benatti, Li Siyuan, Wagner M. Telini, Jamile O. Barboza, Marcelo B. Menezes, Tales R. Nadai, Keyla S. G. Sa, Chirag M. Vaswani, Sahil Gupta, Dario S. Zamboni, Danilo T. Wada, Rodrigo T. Calado, Rene D. R. Oliveira, Paulo Louzada-Junior, Maria Auxiliadora-Martins, Flavio P. Veras, Larissa D. Cunha, Thiago M. Cunha, Rodrigo Luppino-Assad, Marcelo L. Balancin, Sirlei S. Morais, Ronaldo B. Martins, Eurico Arruda, Fernando Chahud, Marcel Koenigkam Santos, Andrea A. Cetlin, Fernando Q. Cunha, Claudia dos Santos, Vera L. Capelozzi, Junya Fukuoka, Rosane Duarte Achcar, Alexandre T. Fabro

CLINICAL AND TRANSLATIONAL MEDICINE (2022)

添加到收藏夹

Letter Cardiac & Cardiovascular Systems

Diversity in the Expressed Genomic Host Response to Myocardial Infarction

Augustin Toma, Claudia dos Santos, Beata Burzynska, Monika Gora, Marek Kiliszek, Natalie Stickle, Holger Kirsten, Leah B. Kosyakovsky, Bo Wang, Sean van Diepen, Slava Epelman, Yishay Szekely, John C. Marshall, Filio Billia, Patrick R. Lawler

CIRCULATION RESEARCH (2022)

添加到收藏夹

Review Cell & Tissue Engineering

Proceedings of the ISCT scientific signature series symposium, Advances in cell and gene therapies for lung diseases and critical illnesses International Society for Cell & Gene Therapy, Burlington VT, US, July 16, 2021

Anthony E. Ting, Elizabeth K. Baker, Josee Champagne, Tushar J. Desai, Claudia C. dos Santos, Irene H. Heijink, Silviu Itescu, Katarina Le Blanc, Michael A. Matthay, Daniel F. McAuley, Lauralynn McIntyre, Shirley H. J. Mei, Biju Parekkadan, Patricia R. M. Rocco, John Sheridan, Bernard Thebaud, Daniel J. Weiss

Summary: This article introduces the ISCT Scientific Signature Series Symposium on Advances in Cell and Gene Therapies for Lung Diseases and Critical Illnesses, which was held at the University of Vermont. The symposium aimed to gather global thought leaders to promote communication and collaboration in the field of cell and gene therapies, bringing innovative solutions and value to patients with respiratory diseases and critical illnesses.

CYTOTHERAPY (2022)

添加到收藏夹

Article Medicine, General & Internal

Cardiovascular signatures of COVID-19 predict mortality and identify barrier stabilizing therapies

Dakota Gustafson, Michelle Ngai, Ruilin Wu, Huayun Hou, Alice Carvalhal Schoffel, Clara Erice, Serena Mandla, Filio Billia, Michael D. Wilson, Milica Radisic, Eddy Fan, Uriel Trahtemberg, Andrew Baker, Chris McIntosh, Chun-Po S. Fan, Claudia C. dos Santos, Kevin C. Kain, Kate Hanneman, Paaladinesh Thavendiranathan, Jason E. Fish, Kathryn L. Howe

Summary: This study prospectively evaluated circulating inflammatory, cardiac, and endothelial cell activation markers in COVID-19 patients and identified microRNA and vascular biomarkers that are prognostic of in-hospital mortality. The study also found that COVID-19 patient plasma can cause endothelial barrier dysfunction, which can be improved with therapeutic interventions.

EBIOMEDICINE (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

DJ-1 binds to Rubicon to Impair LC-3 Associated Phagocytosis

Sahil Gupta, Hajera Amatullah, James N. Tsoporis, Kuiru Wei, Ana Paula Teixeira Monteiro, Amin M. Ektesabi, Amir K. Varkouhi, Chirag M. Vaswani, Amanda Formosa, Alexandre T. Fabro, Sri Nagarjun Batchu, Chris Fjell, James A. Russell, Keith R. Walley, Andrew Advani, Thomas G. Parker, John C. Marshall, Patricia R. M. Rocco, Gregory D. Fairn, Tak Wah Mak, Claudia C. dos Santos

Summary: The ability to effectively clear infection is crucial for host survival. DJ-1 deficiency in bone marrow macrophages (BMM) promotes an increase in L3C-associated phagocytosis during bacterial infection, but not lipopolysaccharide infection. DJ-1 deficiency facilitates the complexing of Rubicon with Beclin-1 and UVRAG, leading to the assembly of autophagolysosomes decorated with LC3 molecules during intact bacterial infection.

CELL DEATH AND DIFFERENTIATION (2022)

添加到收藏夹

Article Microbiology

Cell-Free Dot Blot: an Ultra-Low-Cost and Practical Immunoassay Platform for Detection of Anti-SARS-CoV-2 Antibodies in Human and Animal Sera

Masoud Norouzi, Thang Truong, Katariina Jaenes, Bryce M. Warner, Robert Vendramelli, Kevin Tierney, Darwyn Kobasa, Nikesh Tailor, Pamela Plant, Claudia dos Santos, Shawn Babiuk, Aruna Ambagala, Keith Pardee

Summary: Since its emergence, the COVID-19 pandemic has disrupted various aspects of human life globally and emphasized the need for timely and accessible pandemic response strategies. The cell-free dot blot (CFDB) method is introduced as a practical and low-cost immune diagnostic platform for rapid response and mass immunity screening.

MICROBIOLOGY SPECTRUM (2023)

添加到收藏夹

Article Anesthesiology

Canadian Critical Care Society position statement on Equity, Diversity, Decolonization, and Inclusion

Murdoch Leeies, Sabira Valiani, Varuna Prakash, Wael M. R. Haddara, Ravi Taneja, Kathryn G. Whittemore, Carmen S. Hrymak, Gloria Vazquez-Grande, Bojan N. Paunovic, Ruth E. MacRedmond, James Downar, Catherine A. Farrell, Srinivas Murthy, Babar A. Haroon, Claudia DosSantos, Jason Waechter, Bram Rochwerg, Frederick D'Aragon, Karen E. A. Burns

CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2023)

添加到收藏夹

Letter Respiratory System

Reply: Mesenchymal stromal (stem) cell therapy modulates miR-193b-5p expression to attenuate sepsis-induced acute lung injury

Claudia C. dos Santos, Chirag M. Vaswani, Shirley H. J. Mei, Patricia R. M. Rocco, Daniel J. Weiss, Duncan J. Stewart, W. Conrad Liles

EUROPEAN RESPIRATORY JOURNAL (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Extracellular Vesicles from Different Sources of Mesenchymal Stromal Cells Have Distinct Effects on Lung and Distal Organs in Experimental Sepsis

Natalia G. Blanco, Natalia M. Machado, Ligia L. L. Castro, Mariana A. A. Antunes, Christina M. M. Takiya, Monique R. O. Trugilho, Luana R. R. Silva, Adriana F. Paes F. Leme, Romenia R. Domingues, Bianca A. A. Pauletti, Beatriz T. T. Miranda, Johnatas D. D. Silva, Claudia C. C. dos Santos, Pedro L. L. Silva, Patricia R. M. Rocco, Fernanda F. F. Cruz

Summary: The effects of different sources of MSC-derived extracellular vesicles (EVs), including those obtained from bone marrow (BM), adipose (AD), or lung (L) tissues, on sepsis were investigated. The proteome analysis of EVs revealed that BM-EVs were associated with less organ damage compared with AD-EVs and L-EVs.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Preventing occludin tight-junction disruption via inhibition of microRNA-193b-5p attenuates viral load and influenza-induced lung injury

Chirag M. Vaswani, Amir K. Varkouhi, Sahil Gupta, Amin M. Ektesabi, James N. Tsoporis, Sadiya Yousef, Pamela J. Plant, Adriana L. da Silva, Yuchen Cen, Yi-Chieh Tseng, Sabrina S. Batah, Alexandre T. Fabro, Suzanne L. Advani, Andrew Advani, Howard Leong-Poi, John C. Marshall, Cristiana C. Garcia, Patricia R. M. Rocco, Guillermo M. Albaiceta, Steffen Sebastian-Bolz, Tania H. Watts, Theo J. Moraes, Vera L. Capelozzi, Claudia. C. dos Santos

Summary: Virus-induced lung injury is associated with loss of pulmonary epithelial-endothelial tight junction integrity. The influenza virus exploits miR-193b-5p to target occludin and evade the host antiviral defense system. Inhibiting miR-193b-5p enhances antiviral responses, reduces lung injury, and improves survival.

MOLECULAR THERAPY (2023)

添加到收藏夹

Article Biochemical Research Methods

Mitochondria and cytochrome components released into the plasma of severe COVID-19 and ICU acute respiratory distress syndrome patients

Zhuo Zhen Chen, Lloyd Johnson, Uriel Trahtemberg, Andrew Baker, Saaimatul Huq, Jaimie Dufresne, Peter Bowden, Ming Miao, Ja-An Ho, Cheng-Chih Hsu, Claudia C. dos Santos, John G. Marshall

Summary: Proteomic analysis of COVID-19 and ICU-ARDS plasma identified mitochondrial proteins as potential prognostic markers of severe lung damage. PCR confirmed the presence of mitochondrial DNA in the plasma samples. Cytochrome activity assays demonstrated increased activity in COVID-19 and ICU-ARDS plasma.

CLINICAL PROTEOMICS (2023)

添加到收藏夹

Article Immunology

Severe COVID-19 and non-COVID-19 severe sepsis converge transcriptionally after a week in the intensive care unit, indicating common disease mechanisms

Andy Y. An, Arjun Baghela, Peter Zhang, Reza Falsafi, Amy H. Lee, Uriel Trahtemberg, Andrew J. Baker, Claudia C. dos Santos, Robert E. W. Hancock

Summary: This study compared the gene expression trajectories between severe COVID-19 patients and contemporaneous non-COVID-19 severe sepsis patients during hospitalization. COVID-19 patients had 1,215 differentially expressed genes compared to non-COVID-19 sepsis patients at ICU admission, but the number dropped to 9 genes after one week. The findings highlight the importance of early antiviral treatment for COVID-19 and the potential for heme-related therapeutics.

FRONTIERS IN IMMUNOLOGY (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

DJ-1 Deficiency Protects against Sepsis-Induced Myocardial Depression

James N. N. Tsoporis, Hajera Amatullah, Sahil Gupta, Shehla Izhar, Amin M. M. Ektesabi, Chirag M. M. Vaswani, Jean-Francois Desjardins, Golam Kabir, Ana Paula Teixera Monteiro, Amir K. K. Varkouhi, Nikolaos Kavantzas, Vasileios Salpeas, Ioannis Rizos, John C. C. Marshall, Thomas G. G. Parker, Howard Leong-Poi, Claudia C. C. dos Santos

Summary: Oxidative stress is an early contributor to sepsis-induced myocardial depression, and DJ-1 plays a role as an antioxidant. DJ-1 deficiency improves survival and bacterial clearance in sepsis. This study investigates the role of DJ-1 in sepsis-induced myocardial depression and suggests DJ-1 as a potential therapeutic target.

ANTIOXIDANTS (2023)

添加到收藏夹

Review Critical Care Medicine

Distinct host-response signatures in circulatory shock: a narrative review

Sabri Soussi, Claudia dos Santos, Jacob C. Jentzer, Alexandre Mebazaa, Etienne Gayat, Janine Poss, Hannah Schaubroeck, Filio Billia, John C. Marshall, Patrick R. Lawler

Summary: Circulatory shock is a syndrome characterized by hypotension and tissue hypoperfusion. Recent evidence suggests the existence of distinct host-response patterns and heterogeneous pathways in circulatory shock. This review discusses the potential implications of these findings for personalized treatment in clinical trials.

INTENSIVE CARE MEDICINE EXPERIMENTAL (2023)

添加到收藏夹

Article Multidisciplinary Sciences

Validation of reference gene stability for miRNA quantification by reverse transcription quantitative PCR in the peripheral blood of patients with COVID-19 critical illness

Amanda Formosa, Erica Acton, Amy Lee, Paul Turgeon, Shehla Izhar, Pamela Plant, Jim N. Tsoporis, Sabri Soussi, Uriel Trahtemberg, Andrew Baker, Claudia C. dos Santos

Summary: The COVID-19 pandemic has increased the urgency for studying the host gene response and miRNAs have been identified as potential biomarkers and therapeutic agents. This study used NanoString technology and RT-qPCR to identify suitable reference genes for miRNA expression studies in critically ill COVID-19 patients, concluding that miR-186-5p and miR-148b-3p are appropriate reference genes.

PLOS ONE (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.